Top compounds associated with response to PLCB3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.093 0.03
mRNA masitinib GDSC1000 pan-cancer AAC 0.08 0.03
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.03
mRNA Platin CTRPv2 pan-cancer AAC -0.094 0.03
mRNA BRD-K92856060 CTRPv2 pan-cancer AAC -0.089 0.03
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.088 0.03
mRNA OSI-930 GDSC1000 pan-cancer AAC 0.084 0.04
mRNA Imatinib FIMM pan-cancer AAC 0.39 0.04
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.13 0.04
mRNA PLX4720 GDSC1000 pan-cancer AAC -0.075 0.04
Download CSV